Test Price
2,800 AED✅ Home Collection Available
JPH2 Gene Cardiomyopathy (Familial Hypertrophic Type 17) Genetic Test in UAE | 2,800 AED
Accredited Next‑Generation Sequencing · Home Collection · 3–4 Weeks TAT
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing.
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
Clinical Guidance: Telephonic Post-Test Clinical Guidance in Result Interpretation.
Insurance: Direct Billing Verification via WhatsApp: +971 54 548 8731
Test Overview & Methodology
The JPH2 gene NGS test screens for pathogenic variants causing familial hypertrophic cardiomyopathy type 17, a genetic heart muscle disease. It provides precise molecular diagnosis to guide clinical management and family risk assessment.
Comparative Analysis: NGS vs. Sanger Sequencing
| Feature | Our Test (NGS) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Method | Next‑Generation Sequencing (all exons + flanking regions) | Sanger sequencing of known familial variant only |
| Detection Sensitivity | 99.9% diagnostic sensitivity, novel mutation detection | ~95% for targeted site, cannot identify new mutations |
| Turnaround Time | 3–4 Weeks | 2–3 Weeks (if variant already known) |
| Sample Collection | Home‑based cold‑chain phlebotomy, also accepts DNA/FTA card | Clinic visit usually required |
Physician Insight & Safety Protocols
“As a medical genetics consultant, I emphasize that a pathogenic JPH2 variant must be correlated with your echocardiogram, ECG, and family history. Never interpret this result in isolation. Please discuss all findings with your treating cardiologist before making any lifestyle or treatment changes. Sudden cardiac risk is serious, and expert guidance is your strongest protection.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA License: 9294403
Advisory: Medication Continuation
⚠️ Medication Warning
Do not discontinue prescribed heart medications (beta‑blockers, calcium channel blockers, diuretics) without consulting your doctor. This genetic test is a diagnostic tool, not a substitute for ongoing cardiac care.
Clinical Exclusion Criteria & Emergency Red Flags
Exclusion Criteria (Per UAE Federal Decree-Law No. 4 of 2016 on Medical Liability & DHA Protocols)
- Minors (under 18 years) without a parent/legal guardian present for informed consent.
- Severe cognitive impairment or active psychiatric condition preventing valid informed consent.
- Recent blood transfusion (within 2 weeks) that may introduce donor DNA interference.
- Known contraindication to phlebotomy (severe bleeding disorder, unstable acute illness).
🚨 Emergency Red Flags – Seek Immediate Medical Attention
- Sudden chest pain, pressure, or tightness
- Shortness of breath that worsens with minimal activity or at rest
- Fainting (syncope) or near‑fainting episodes, especially during exertion
- Forceful, irregular heartbeat or palpitations lasting more than a few minutes
If you experience any of these, call 998 (UAE ambulance) or go to the nearest emergency department immediately.
Patient FAQ & Clinical Guidance
1. What exactly does the JPH2 genetic test detect?
This test sequences the entire JPH2 gene to identify disease‑causing mutations linked to hypertrophic cardiomyopathy type 17, giving you a definitive molecular diagnosis.
2. Who should consider this genetic test?
You should test if you have a family history of hypertrophic cardiomyopathy, unexplained heart muscle thickening, or a known JPH2 variant in a relative.
3. How is the sample collected and what safety measures are in place?
A DHA‑licensed phlebotomist visits your home with a sterile, cold‑chain kit to draw a small blood sample; you may also provide DNA on an FTA card. The entire process follows UAE infection control standards.
4. Is genetic counselling mandatory before testing?
Yes, a pre‑test genetic counselling session (telephonic or face‑to‑face) is required to explain the implications, inheritance pattern, and possible outcomes. No sample is processed without documented informed consent.
UAE Regulatory & Data Privacy Adherence
We comply with the UAE Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Your genetic data is encrypted, stored securely, and never shared without your explicit consent. Clinical testing follows Federal Decree-Law No. 4 of 2016 on Medical Liability to ensure patient safety and valid informed consent.
Clinical & Logistical Metadata
| Test Name | JPH2 Gene Cardiomyopathy (Familial Hypertrophic Type 17) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood (Peripheral) – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM) |
| Methodology Used | Next-Generation Sequencing (NGS) – Full gene sequencing including all exons and flanking regions |
| ICD-10-CM Code | I42.2 (Hypertrophic cardiomyopathy, other) |
| LOINC Code | 21636-6 (JPH2 gene full sequencing) |
| DHA Facility License & Laboratory Address | License #1143, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians